Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Exploring the Antiviral Mechanism of NK cells against HSV-2

FY 2012-13

Summary
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to control or prevent HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
283843
Name
Lee Amanda J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Exploring the Antiviral Mechanism of NK cells against HSV-2
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Animal Handling; Elisa; Flow Cytometry; Herpes Simplex Virus Type 2; Interferons; Interleukin-15; Natural Killer Cells; Nitric Oxide; Viral Titering
Abstract
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to control or prevent HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lee, Amanda J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2012-13) | Canada Spends